We are pleased to invite investors and analysts to participate in our virtual event on Monday, 11 March 2024, highlighting key data presented at 2024 Muscular Dystrophy Association (MDA) and Alzheimer's & Parkinson's Diseases (AD/PD) conferences.   15:00 – 16:30 CET / 14:00 – 15:30 GMT 10:00 – 11:30 AM EDT / 07:00 – 08:30 AM PDT   The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:00 CET on the day of the event. >click here   Access to virtual event (pre-registration required) Please pre-register for our webinar here.*   Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.   A replay of the webinar will be available via > ir.roche.com *privacy notice         Best regards,
Bruno Eschli Head of Investor Relations	Loren Kalm Head of Investor Relations, North America

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.